These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 25632113)

  • 1. Designer receptors enhance memory in a mouse model of Down syndrome.
    Fortress AM; Hamlett ED; Vazey EM; Aston-Jones G; Cass WA; Boger HA; Granholm AC
    J Neurosci; 2015 Jan; 35(4):1343-53. PubMed ID: 25632113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome.
    Hamlett ED; Ledreux A; Gilmore A; Vazey EM; Aston-Jones G; Boger HA; Paredes D; Granholm AE
    Neurobiol Dis; 2020 Feb; 134():104616. PubMed ID: 31678403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model.
    Lockrow J; Boger H; Gerhardt G; Aston-Jones G; Bachman D; Granholm AC
    J Alzheimers Dis; 2011; 23(3):471-89. PubMed ID: 21098982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
    Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
    Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.
    Lockrow J; Prakasam A; Huang P; Bimonte-Nelson H; Sambamurti K; Granholm AC
    Exp Neurol; 2009 Apr; 216(2):278-89. PubMed ID: 19135442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs.
    Chen X; Choo H; Huang XP; Yang X; Stone O; Roth BL; Jin J
    ACS Chem Neurosci; 2015 Mar; 6(3):476-84. PubMed ID: 25587888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.
    Faizi M; Bader PL; Tun C; Encarnacion A; Kleschevnikov A; Belichenko P; Saw N; Priestley M; Tsien RW; Mobley WC; Shamloo M
    Neurobiol Dis; 2011 Aug; 43(2):397-413. PubMed ID: 21527343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of noradrenergic terminals in the reticular thalamus delays arousal from propofol anesthesia in mice.
    Zhang Y; Fu B; Liu C; Yu S; Luo T; Zhang L; Zhou W; Yu T
    FASEB J; 2019 Jun; 33(6):7252-7260. PubMed ID: 30860868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome.
    Rueda N; Flórez J; Martínez-Cué C
    Behav Brain Res; 2008 Apr; 188(2):355-67. PubMed ID: 18178265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.
    Jardanhazi-Kurutz D; Kummer MP; Terwel D; Vogel K; Dyrks T; Thiele A; Heneka MT
    Neurochem Int; 2010 Nov; 57(4):375-82. PubMed ID: 20144675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: altered behavior in the elevated plus maze and open field.
    Coussons-Read ME; Crnic LS
    Behav Genet; 1996 Jan; 26(1):7-13. PubMed ID: 8852727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome.
    Salehi A; Faizi M; Colas D; Valletta J; Laguna J; Takimoto-Kimura R; Kleschevnikov A; Wagner SL; Aisen P; Shamloo M; Mobley WC
    Sci Transl Med; 2009 Nov; 1(7):7ra17. PubMed ID: 20368182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.
    Rueda N; Flórez J; Martínez-Cué C
    Neurosci Lett; 2008 Mar; 433(1):22-7. PubMed ID: 18226451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.
    Gomez JL; Bonaventura J; Lesniak W; Mathews WB; Sysa-Shah P; Rodriguez LA; Ellis RJ; Richie CT; Harvey BK; Dannals RF; Pomper MG; Bonci A; Michaelides M
    Science; 2017 Aug; 357(6350):503-507. PubMed ID: 28774929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience-dependent reduction of soluble β-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome.
    Sansevero G; Begenisic T; Mainardi M; Sale A
    Exp Neurol; 2016 Sep; 283(Pt A):49-56. PubMed ID: 27288239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine.
    Szot P; Franklin A; Miguelez C; Wang Y; Vidaurrazaga I; Ugedo L; Sikkema C; Wilkinson CW; Raskind MA
    Neuropharmacology; 2016 Feb; 101():76-86. PubMed ID: 26362360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome.
    Dang V; Medina B; Das D; Moghadam S; Martin KJ; Lin B; Naik P; Patel D; Nosheny R; Wesson Ashford J; Salehi A
    Biol Psychiatry; 2014 Feb; 75(3):179-88. PubMed ID: 23827853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.